JP2007106688A5 - - Google Patents

Download PDF

Info

Publication number
JP2007106688A5
JP2007106688A5 JP2005297991A JP2005297991A JP2007106688A5 JP 2007106688 A5 JP2007106688 A5 JP 2007106688A5 JP 2005297991 A JP2005297991 A JP 2005297991A JP 2005297991 A JP2005297991 A JP 2005297991A JP 2007106688 A5 JP2007106688 A5 JP 2007106688A5
Authority
JP
Japan
Prior art keywords
cytokine
related gene
units
expression inhibitor
weight hyaluronan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2005297991A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007106688A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2005297991A priority Critical patent/JP2007106688A/ja
Priority claimed from JP2005297991A external-priority patent/JP2007106688A/ja
Priority to US11/438,819 priority patent/US20070099867A1/en
Priority to AU2006220353A priority patent/AU2006220353A1/en
Priority to NO20064337A priority patent/NO20064337L/no
Priority to CA2560844A priority patent/CA2560844C/en
Priority to RU2006134169/15A priority patent/RU2342148C2/ru
Priority to EP06020126A priority patent/EP1767211B1/en
Priority to ARP060104194A priority patent/AR056091A1/es
Priority to AT06020126T priority patent/ATE552005T1/de
Priority to BRMU8603015-9U priority patent/BRMU8603015U/pt
Publication of JP2007106688A publication Critical patent/JP2007106688A/ja
Publication of JP2007106688A5 publication Critical patent/JP2007106688A5/ja
Pending legal-status Critical Current

Links

JP2005297991A 2005-05-24 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤 Pending JP2007106688A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP2005297991A JP2007106688A (ja) 2005-10-12 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤
US11/438,819 US20070099867A1 (en) 2005-05-24 2006-05-23 Pharmaceutical agent containing hyaluronan as an active ingredient
AU2006220353A AU2006220353A1 (en) 2005-05-24 2006-09-20 Pharmaceutical Agent Containing Hyaluronan as an Active Ingredient
RU2006134169/15A RU2342148C2 (ru) 2005-09-26 2006-09-25 Фармацевтическое средство, содержащее гиалуронан в качестве активного ингредиента
CA2560844A CA2560844C (en) 2005-09-26 2006-09-25 Pharmaceutical agent containing hyaluronan as an active ingredient
NO20064337A NO20064337L (no) 2005-09-26 2006-09-25 Farmasoytisk middel inneholdende hyaluronan som en aktiv ingrediens
EP06020126A EP1767211B1 (en) 2005-09-26 2006-09-26 Pharmaceutical agent containing hyaluronan as an active ingredient
ARP060104194A AR056091A1 (es) 2005-09-26 2006-09-26 Agente farmaceutico que contiene hialuronano como ingrediente activo
AT06020126T ATE552005T1 (de) 2005-09-26 2006-09-26 Pharmazeutische zusammensetzung hyaluronan als aktive komponente enthaltend
BRMU8603015-9U BRMU8603015U (pt) 2005-09-26 2006-09-26 agente farmacêutico contendo hialuronano como componente ativo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005297991A JP2007106688A (ja) 2005-10-12 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤

Publications (2)

Publication Number Publication Date
JP2007106688A JP2007106688A (ja) 2007-04-26
JP2007106688A5 true JP2007106688A5 (enExample) 2007-11-29

Family

ID=38032837

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2005297991A Pending JP2007106688A (ja) 2005-05-24 2005-10-12 サイトカイン関連遺伝子及びケモカイン関連遺伝子の発現抑制剤

Country Status (1)

Country Link
JP (1) JP2007106688A (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6363119B2 (ja) * 2013-03-14 2018-07-25 アナコティ リミテッド ヒアルロン酸誘導体

Similar Documents

Publication Publication Date Title
JP2008513467A5 (enExample)
EP1992645A4 (en) NEW LOW-MOLECULAR HYALURONIC ACID AND / OR SALT AND COSMETIC PREPARATION, PHARMACEUTICAL COMPOSITION AND FOOD COMPOSITION THEREWITH
ECSP088239A (es) Composición de liberación de fármaco sostenida
CY1119839T1 (el) Στερεες μορφες δοσεως μπενταμουστινης
ECSP088240A (es) Composición de trazodona para administración una vez por día
JP2010047612A5 (enExample)
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
CL2007001993A1 (es) Compuestos derivados de pirimidilciclopentanos hidroxilados y metoxilados; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una enfermedad inflamatoria, hiperproliferante, cardiovascular, neurodegenerat
JP2010514554A5 (enExample)
NO20074872L (no) Pyrazoler
EA200970081A1 (ru) Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения
WO2006044421A3 (en) Cardiac safe, rapid medication delivery
JP2010508499A5 (enExample)
UY32503A (es) Formulación pesticida de uso agrícola a base de avermectina y un agente fotoprotector
DK2794665T3 (da) Ikke-antikoagulative glycosaminoglycaner omfattende disaccharid-gentagelsesenhed og medicinsk anvendelse deraf
NZ608239A (en) Aqueous drug delivery system comprising off - flavor masking agent
JP2011507976A5 (enExample)
EP2279726A3 (en) Compositions and methods using same for delivering agents into a target organ protected by a blood barrier
JP2004525917A5 (enExample)
JP2009516719A5 (enExample)
TW200716616A (en) Modulators of CCR-5 activity
ATE553755T1 (de) Stärke enthaltende beschichtungszusammensetzung
JP2006335694A5 (enExample)
JP2006522806A5 (enExample)